targeting calpain-2 for people living with amyotrophic lateral sclerosis (ALS). With the clinical hold lifted, Amylyx is now working to open U.S. sites for screening, enrollment, and dosing.

Both mothers emphasize that prevention and awareness are key when it comes to sudden cardiac arrest. They have both experienced the heartbreaking loss of their 17-year-old sons in the same manner, and ...

neura.edu.au Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disorder of the motor neurons in the motor cortex, brainstem and spinal cord. A combination of upper and ...